Abstract
A dose response curve for LRFD6a-a potent LRF agonist-was established in normal midluteal phase women. At low doses (3-10μg) an acute stimulatory effect on gonadotropins and ovarian steroidogenesis of estradiol and progesterone was observed. Despite large increases in circulating gonadotropins following the highest dose (30/¿g LRFD6a), no acute changes in plasma steroids were noted. A sharp drop in progesterone was present after 3 days, with significant shortening of the cycle in 3 of 4 subjects in the group. While the stimulatory effect may be due to gonadotropin release and local action, the luteolytic effect observed is suggested to be a consequence of the direct inhibitory effect of the analog on ovarian function.
Similar content being viewed by others
References
Schally A.V., Commaru Schally A.M., Martin A.L Present status of the use of LHRH and its analogs in the diagnosis and therapy of infertility. In: Belling CG., Wentz A.C. (Eds.), The LH-releasing hormone. Masson Inc., New York, 1980, p. 1.
Humphrey R.P., Windsor B.C., Boinsley F.G., Edgren R.A. Antifertility effects of an analog of luteinizing hormone releasing hormone (LHRH) in rats. Contraception 19: 625, 1976.
Lemay A., Labrie F., Ferland L., Raynaud J.P. Possible luteolytic effects of luteinizing hormone-releasing hormone in normal women. Fertil. Steril. 31: 29, 1976.
Casper R., Yen S. Induction of luteolysis in the human with a long-acting analog of luteinizing hormone-releasing factor. Science 205: 408, 1979.
Bex F.J., Corbin A. Mechanism of the postcoital contraceptive effect of luteinizing hormone-releasing hormone: ovarian luteinizing hormone receptor interactions. Endocrinology 105: 139, 1979.
Clayton R.N., Harwood J.P., Catt K.J. Gonadotropin-releasing hormone analogue binds to luteal cells and inhibits progesterone production. Nature 282: 90, 1979.
Ekholm C., Clark M.R., Magnusson C., Isaksson O., Le-Maire W.J. Ovulation induced by a gonadotropin releasing hormone analog in hypophysectomized rats involves prostaglandins. Endocrinology 110: 288, 1982.
Catt K.J., Harwood J.P., Clayton R.N., Davies T.F., Chan V., Katikineni M., Nozu K., Dufau M.L Regulation of peptide hormone receptors and gonadal steroidogenesis. Recent Prog. Horm. Res. 36: 557, 1980.
Jaffe B.M., Behrman H.R. Methods of hormone radioimmunoassay. Academic Press Inc., New York, 1979.
Koyama T., Ohkura T., Kumasaka T., Saito M. Effect of postovulatory treatment with a luteinizing hormone-releasing hormone analog on the plasma level of progesterone in women. Fertil. Steril. 30: 549, 1978.
Stone S.C., Dickey R.P., Kastin A.J., Schally A.V. LHRH and steroid levels in normal ovulatory women. Obstet. Gynecol. 48:146, 1976.
Caldwell B.V., Rotchell Y.E., Pang C.Y., Anderson G.G., Kase N., Behrman H.R. Comparative study of high dose chorionic gonadotropin on the human and rat corpus luteum and effect of gonadotropin-releasing hormone on human luteal function. Am. J. Obstet. Gynecol. 126: 458, 1980.
Lemay A., Faure N., Labrie F. Sensitivity of pituitary and corpus luteum response to single intranasal administration of (D-Ser [TBU]6-des-Gly-NH210) luteinizing hormone-releasing hormone ethylamide (Buserelin) in normal women. Fertil. Steril. 37:193, 1982.
Sheehan K.L., Casper R.F., Yen S. Induction of luteolysis by luteinizing hormone-releasing factor (LRF) agonist: sensitivity, reproducibility and reversibility. Fertil. Steril. 37: 209, 1982.
Sheehan K.L., Casper R.F., Yen S. Luteal phase defects induced by an agonist of luteinizing hormone-releasing factor: a model for fertility control. Science 215:170, 1982.
Corbin A., Bex F.J. Luteinizing hormone releasing hormone agonists induce ovulation in hypophysectomized proestrous rats: direct ovarian effect. Life Sci. 29:185, 1981.
Casper R.F., Erikson G.F., Rebar R.W., Yen S. The effect of luteinizing hormone releasing factor and its agonist on cultured human granulosa cells. Fertil. Steril. 406: 37, 1982.
Tureck R.W., Mastroianni L., Strauss III J.F. Inhibition of human granulosa cell progesterone secretion by a gonadotropin-releasing-hormone agonist. J. Clin. Endocrinol. Metab. 54:1078, 1982.
Popkin R., Brambly T.A., Currie A., Shaw R.W., Baird D.T., Fraser H.M. Specific binding of luteinizing hormone releasing hormone to human luteal tissue. Biochem. Biophsy. Res. Commun. 114: 750, 1983.
Meldrum D.R., Tsao Z., Monroe S.E., Braunstein G.D., Sladek J., Lu J.K.H., Vale W., Rivier J., Judd H.L., Chang R.J. Stimulation of LH fragments with reduced bioactivity following GnRH agonist administration in women. J. Clin. Endocrinol. Metab. 58: 755, 1984.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Barnea, E.R., Maheux, R., Caldwell, B.V. et al. LRFD6ahas a dose-related stimulatory or inhibitory effect on the ovary in normal luteal phase women. J Endocrinol Invest 8, 297–302 (1985). https://doi.org/10.1007/BF03348501
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03348501